Systematic Reviews and Meta-Analyses
Systematic reviews are an umbrella term for a number of different review designs, all with specific goals (e.g., identify scope of available research or gaps, reduce bias, statistically combine and analyze results from multiple studies). They differ from basic literature review articles that qualitatively summarize the literature on a topic and do not necessarily have inclusion or exclusion criteria.
Epidemiological meta-analyses are quantitative types of systematic reviews, in which summary measures of exposure–outcome associations are calculated based on the results of a selection of existing studies. In other words, a meta-analysis statistically combines the results from multiple studies, with the goal of calculating more precise measures, increasing sample size, or reducing bias in the combined results. The goal of meta-analysis is to obtain a more robust understanding of the relationship between an exposure and a health outcome than could be obtained from a single study. While meta-analyses are considered to be strong research designs because of their formal, statistical characteristics, they are not without weakness or critics. For instance, existing studies included in a meta-analysis may have strengths and limitations of their own.
For this Discussion, you examine the validity and strengths and limitations of systematic reviews and meta-analyses in epidemiological research.
Resources
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
· Driscoll, A., Grant, M. J., Carroll, D., Dalton, S., Deaton, C., Jones, I., Lehwaldt, D., McKee, G., Munyombwe, T., & Astin, F. (2018).
The effect of nurse-to-patient ratios on nurse-sensitive patient outcomes in acute specialist units: A systematic review and meta-analysisLinks to an external site..
European Journal of Cardiovascular Nursing,
17(1), 6–22.
· Seidler, A. L., Hunter, K. E., Cheyne, S., Berlin, J. A., Ghersi, D., & Askie, L. M. (2020).
Prospective meta-analyses and Cochrane’s role in embracing next-generation methodologiesLinks to an external site..
Cochrane Database of Systematic Reviews,
10, ED000145.
· Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., … Moher, D. (2021).
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsLinks to an external site..
Journal of Clinical Epidemiology,
134, 178–189.
· Haidich, A. B. (2010).
Meta-analysis in medical researchLinks to an external site..
Hippokratia, 14 (Suppl. 1), 29–37.
· Melnyk, B. M., Kelly, S. A., Stephens, J., Dhakal, K., McGovern, C., Tucker, S., Hoying, J., McRae, K., Ault, S., Spurlock, E., & Bird, S. B. (2020).
Interventions to improve mental health, well-being, physical health, and lifestyle behaviors in physicians and nurses: A systematic reviewLinks to an external site..
American Journal of Health Promotion,
34(8), 929–941.
· Siddaway, A. P., Wood, A. M., & Hedges, L. V. (2019).
How to do a systematic review: A best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-synthesesLinks to an external site..
Annual Review of Psychology,
70, 747–770.
To prepare:
· Review the studies and articles provided in the Learning Resources. Consider the strengths and limitations of systematic reviews and meta-analyses. Make sure you are clear on the difference between the two approaches.
By Day 3 of Week 8
Post a brief summary of your informed opinion regarding the validity of the use of systematic reviews
and meta-analyses in epidemiological research. Include
at least two strengths or limitations of each technique. Provide evidence from
at least one of the articles in the Learning Resources to support and justify your position.
By Day 6 of Week 8
Post substantive responses to
at least two colleagues
on two different days who expressed a differing view to your own in their initial post. Include information from the Learning Resources in your responses as appropriate. You may expand on your peer’s posting with additional insight and resources about meta-analyses, ask a question to further the Discussion, or offer polite disagreement or critique, supported with evidence. You may also make a suggestion or comment that guides or facilitates the Discussion.
RESPOND TO THIS DISCUSSION POST
Yvonne
Systematic Reviews and Meta-Analyses in Epidemiological Research
Systematic reviews and meta-analyses are potent tools in epidemiological research, providing high-quality evidence to guide healthcare decision-making. A systematic review aims to comprehensively identify, evaluate, and synthesize all available evidence on a specific research question using a structured methodology. A meta-analysis is a subtype of systematic review that applies statistical techniques to quantitatively combine results from multiple studies to provide more precise estimates of effects (Seidler et al., 2020). Both methods are crucial for informing clinical practice, policymaking, and identifying gaps in the literature. However, they are not without limitations.
The validity of systematic reviews lies in their methodological rigor. By following transparent processes and predefined inclusion and exclusion criteria, systematic reviews reduce bias and improve reproducibility. The PRISMA 2020 statement, updated by Page et al. (2021), outlines essential criteria to enhance the transparency and quality of systematic reviews, including guidance on reporting methods, data sources, and synthesis strategies. This updated standard strengthens the reliability of systematic reviews by ensuring consistency and completeness in reporting.
One significant strength of systematic reviews is their ability to summarize a large body of research in an objective manner. They help clinicians and policymakers quickly understand what is known about a topic without having to review each individual study. Another strength is their potential to identify gaps in knowledge and inform future research agendas. However, limitations include the risk of publication bias, where only studies with positive results are published and included, and heterogeneity among studies, which can make meaningful comparisons difficult.
Meta-analyses enhance the impact of systematic reviews by statistically combining results to improve power and precision. By pooling data, meta-analyses can detect small but clinically significant effects that individual studies may miss. For example, Driscoll et al. (2018) conducted a meta-analysis on nurse-to-patient ratios and found that lower ratios were significantly associated with better patient outcomes. This level of evidence supports workforce policy development and quality improvement initiatives.
Despite their strengths, meta-analyses have limitations. One major concern is the variability in study quality. If a meta-analysis includes poorly designed studies, its overall conclusions may be flawed. Additionally, publication bias and selective reporting can skew results. As Haidich (2010) noted, the statistical combination of biased studies does not eliminate the biases themselves. This limitation underlines the importance of critically appraising the quality of included studies using established tools before conducting meta-analysis.
Prospective meta-analyses, as discussed by Seidler et al. (2020), offer an innovative solution to some of these challenges by pre-planning the inclusion of studies and coordinating efforts across multiple research teams. This approach can improve consistency and reduce selection bias, strengthening the validity of findings.
In conclusion, systematic reviews and meta-analyses are indispensable for synthesizing evidence in epidemiological research. When conducted and reported properly, they offer high-level evidence to guide practice and policy. Nonetheless, researchers must be cautious of limitations such as publication bias, study quality variation, and heterogeneity. Following guidelines like PRISMA and exploring newer models such as prospective meta-analyses can help mitigate these concerns and enhance the utility of these methodologies in health research.
References
Driscoll, A., Grant, M. J., Carroll, D., Dalton, S., Deaton, C., Jones, I., … & Astin, F. (2018). The effect of nurse-to-patient ratios on nurse-sensitive patient outcomes in acute specialist units: A systematic review and meta-analysis.
European Journal of Cardiovascular Nursing, 17(1), 6–22.
Links to an external site.
Haidich, A. B. (2010). Meta-analysis in medical research.
Hippokratia, 14(Suppl. 1), 29–37.
Links to an external site.
Melnyk, B. M., Kelly, S. A., Stephens, J., Dhakal, K., McGovern, C., Tucker, S., … & Bird, S. B. (2020). Interventions to improve mental health, well-being, physical health, and lifestyle behaviors in physicians and nurses: A systematic review.
American Journal of Health Promotion, 34(8), 929–941.
Links to an external site.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., … & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Journal of Clinical Epidemiology, 134, 178–189.
Links to an external site.
Seidler, A. L., Hunter, K. E., Cheyne, S., Berlin, J. A., Ghersi, D., & Askie, L. M. (2020). Prospective meta-analyses and Cochrane’s role in embracing next-generation methodologies.
Cochrane Database of Systematic Reviews, 10, ED000145.
Links to an external site.
